GSA Capital Partners’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $752K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $516K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $251K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $865K | Buy |
|
|||||
|
2021
Q2 | $685K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $262K | Buy |
|
|||||
|
2020
Q1 | $229K | Sell |
|
|||||
|
2019
Q4 | $353K | Sell |
|
|||||
|
2019
Q3 | $678K | Sell |
|
|||||
|
2019
Q2 | $2.07M | Buy |
|
|||||
|
2019
Q1 | $1.68M | Sell |
|
|||||
|
2018
Q4 | $1.33M | Buy |
|
|||||
|
2018
Q3 | $1.44M | Sell |
|
|||||
|
2018
Q2 | $1.71M | Buy |
|
|||||
|
2018
Q1 | $413K | Sell |
|
|||||
|
2017
Q4 | $509K | Sell |
|
|||||
|
2017
Q3 | $530K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $2.89M | Buy |
|
|||||
|
2016
Q4 | $3.26M | Sell |
|
|||||
|
2016
Q3 | $3.64M | Sell |
|
|||||
|
2016
Q2 | $3.89M | Buy |
|
|||||
|
2016
Q1 | $2.23M | Buy |
|
|||||
|
2015
Q4 | $2.5M | Buy |
|
|||||
|
2015
Q3 | $1.98M | Buy |
|
|||||
|
2015
Q2 | $1.69M | Sell |
|
|||||
|
2015
Q1 | $2.86M | Sell |
|
|||||
|
2014
Q4 | $2.58M | Sell |
|
|||||
|
2014
Q3 | $1.4M | Buy |
|
|||||
|
2014
Q2 | $1.03M | Buy |
|